Pro Medicus, Ltd. · ASX:PME
Pro Medicus — PAC Partners Conference (September 2015)
22 slides from Pro Medicus's conference presentation, Sep 30, 2015
Slide 1: Investor Presentation September 2015
For personal use only Investor Presentation September 2015
Slide 2: Pro Medicus (ASX:PME) listed company
Pro Medicus (ASX:PME) listed company For personal use only Visage Imaging – wholly owned subsidiary Offices in three continents Over 40 Software Engineers EU Headquarters / R&D Berlin, Germany US Headquarters San Diego, CA Group Headquarters Melbourne
Slide 3: Pro Medicus Product Suite
For personal use only PME Ltd Pro Medicus Visage 7 * OEM (RIS) Product Suite Visage RIS * Pro Medicus.net
Slide 4: visageimaging.com
visageimaging.com – number 1 in…. For personal use only
Slide 5: Current Imaging Technology: Massive Data explosion
Current Imaging Technology For personal use only • Massive Data explosion • Higher image density - CT leaps from 64 Slices to 256 and now 640 • 3T MRI – over 4 times the dataset of 1.5T • Functional Imaging eg PET scan often > 1.5 to 2 Gig Gigabytes • Digital Breast Tomosynthesis (DBT) files can be
Slide 6: "Deconstructed PACS" Architecture
“Deconstructed PACS” Architecture For personal use only
Slide 7: "Deconstructed" PACS - VNA
“Deconstructed” PACS - VNA For personal use only Radiology Urology Gastroenterology Oncology Cardiology Neurology
Slide 8: "Enterprise Viewer"
“Enterprise Viewer” For personal use only VNA use surging – VNA's projected to store 31% of new imaging studies worldwide by 2016 InMedica, May 2012 Of late, imaging IT has been a "barren" field of technology innovation Reiner & McKinley, JDI, June 2012 No single vendor will do Enterprise Imaging 20
Slide 9: Introducing Visage
For personal use only Introducing Visage 7
Slide 10: Opportunities - North America
Opportunities - North America For personal use only • Worlds largest market • PACS market estimated at > US $1.5B pa and growing • Paradigm shift to “Deconstructed PACS” – best in breed approach • Market fragmented - in process of consolidating • Visage - recognised leader in Enterprise viewing & 3D
Slide 11: North America
North America For personal use only • Four deals in the last 10 months – network affect • Growing pipeline. • Opportunities spread across key market segments: • Enterprise Hospitals • Imaging Centres • Teleradiology/Remote reading groups • Industry consolidation to create further opportunities.
Slide 12: North America – vRad
For personal use only North America – vRad
Slide 13: For personal use only
VISN 23 pro¢medicus OUR SUPPORT. YOUR SUCCESS. American Samoa - ated = (OUR SUPPORT. YOUR SUCCESS.
Slide 14: Large US Health System – May 2014
Large US Health System – May 2014 For personal use only • >$20M minimum over 6 years • Visage 7.0 to be used for all diagnostic interpretation and clinical (referrer distribution) • Operational (transaction based) model • Significant upside as Visage technology is rolled out • Implementation still i
Slide 15: WellSpan Health – November 2014
WellSpan Health – November 2014 For personal use only • $8M - 7 year deal • Visage 7.0 to be used for all diagnostic interpretation and clinical (referrer distribution) • Operational (transaction based) model • Validation deconstructed model rapidly gaining momentum • Comes on top of other recent US
Slide 16: Zwanger Pesiri – January 2015
Zwanger Pesiri – January 2015 For personal use only • $5M - 5 year deal • Operational (transaction based) model • Key player in Private/Imaging centre market • Fully up and running • Technology delivering significant benefits • Excellent East Coast reference site
Slide 17: UF Medical System – April 2015
UF Medical System– April 2015 For personal use only • $9.5M - 7 year deal • Visage 7.0 to be used for all diagnostic interpretation and clinical (referrer distribution) • Hybrid operational and capital model • Comes on top of other recent US wins • University Hospital/Academic reference site. • Impl
Slide 18: Allegheny (AHN) – Sept 2015
Allegheny (AHN) – Sept 2015 For personal use only • $11.0M - 5 year deal • Visage 7.0 to be used for all diagnostic interpretation and clinical (referrer distribution) • Transaction based model • 4th major win in under 12 months. • Affiliated with Blue Cross/Blue Shield
Slide 19: Operational (Transaction) Model
Operational (Transaction) Model For personal use only • Alternative to capital model • Favoured in recent US contracts • Model based on guaranteed minimums • Contracted minimums increase to >$60M • Upside as client examination volumes grow • Annuity style revenue stream – greater predictability
Slide 20: Margin Expansion
Margin Expansion For personal use only • Highly scalable offering • No Capex (HW) – SW only model • Training & Installation – charged as Professional services • Relatively Fixed Cost base • Margin growth as footprint increases
Slide 21: Growth Drivers
Growth Drivers For personal use only • Transaction growth (above minimums) from existing clients • Expand current footprint via new deals • Margin expansion with future contracts • Continue to build out pipeline • Introduce new products • Extend to other markets
Slide 22: For personal use only
For personal use only Investor Presentation September 2015
Pro Medicus — PAC Partners Conference (September 2015) on 6ix